| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:63247000:2096 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:63247000:2096?format=raw |
LEADER: 02096mam a2200409 a 4500
001 4054060
005 20221027025106.0
008 960523s1996 maua b 001 0 eng c
010 $a 96025407
020 $a0674068092 (alk. paper)
035 $a(OCoLC)ocm34912731
035 $9AMG3624HS
035 $a(NNC)4054060
035 $a4054060
040 $aDNLM/DLC$cDLC$dNLM$dC#P$dOrLoB-B
050 00 $aRC271.I47$bL68 1996
060 00 $a1997 C-291
060 10 $aQZ 266$bL922b 1996
082 00 $a616.99/4061$220
100 1 $aLöwy, Ilana,$d1948-$0http://id.loc.gov/authorities/names/n90696656
245 10 $aBetween bench and bedside :$bscience, healing, and interleukin-2 in a cancer ward /$cIlana Löwy.
246 30 $aScience, healing, and interleukin-2 in a cancer ward
260 $aCambridge, Mass. :$bHarvard University Press,$c1996.
300 $a370 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. [289]-361) and index.
505 00 $tIntroduction: Observing a Clinical Experiment in Context --$g1.$tThe Culture of Clinical Experimentation in Oncology --$g2.$tCancer Immunotherapy, 1894-1979 --$g3.$tCancer Immunotherapy and Mass Production of Biological Agents, 1980-1990 --$g4.$tThe IL-2 Trial at the Cancer Foundation: A Personal View --$g5.$tMaking the IL-2 Trial Work: Professional Cultures, Jurisdictions, and Practices --$g6.$tA Science-Laden Pathology between Bench and Bedside.
650 0 $aInterleukin-2$xTherapeutic use.
650 0 $aCancer$xImmunotherapy.$0http://id.loc.gov/authorities/subjects/sh87002642
650 0 $aOncologists$xAttitudes.
650 0 $aClinical trials$xPhilosophy.
650 12 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 22 $aInterleukin-2$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D007376Q000627
650 22 $aClinical Trials as Topic.$0https://id.nlm.nih.gov/mesh/D002986
655 2 $aPersonal Narrative.$0https://id.nlm.nih.gov/mesh/D062210
852 00 $boff,hsl$hRC271.I47$iL68 1996